Skip to main content

Table 2 Tumor staging information of the 307 patients with hepatocellular carcinoma

From: Optimal staging system for predicting the prognosis of patients with hepatocellular carcinoma in China: a retrospective study

Staging system Patients (%)
CLIP  
 0 95 (30.9)
 1 86 (28.0)
 2 42 (13.7)
 3 53 (17.3)
 4 21 (6.8)
 5 8 (2.6)
 6 2 (0.7)
BCLC  
 0 10 (3.3)
 A 45 (14.7)
 B 32 (10.4)
 C 196 (63.8)
 D 24 (7.8)
TNMa  
 I 133 (43.3)
 II 41 (13.4)
 IIIA 15 (4.9)
 IIIB 37 (12.0)
 IIIC 11 (3.6)
 IVA 41 (13.4)
 IVB 29 (9.4)
CS  
 Ia 49 (16.0)
 Ib 42 (13.7)
 IIa 51 (16.6)
 IIb 63 (20.5)
 IIIa 90 (29.3)
 IIIb 12 (3.9)
  1. aSeventh edition